Correlation Between Corvus Pharmaceuticals and Aytu BioScience

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Corvus Pharmaceuticals and Aytu BioScience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Corvus Pharmaceuticals and Aytu BioScience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Corvus Pharmaceuticals and Aytu BioScience, you can compare the effects of market volatilities on Corvus Pharmaceuticals and Aytu BioScience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Corvus Pharmaceuticals with a short position of Aytu BioScience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Corvus Pharmaceuticals and Aytu BioScience.

Diversification Opportunities for Corvus Pharmaceuticals and Aytu BioScience

-0.86
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Corvus and Aytu is -0.86. Overlapping area represents the amount of risk that can be diversified away by holding Corvus Pharmaceuticals and Aytu BioScience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aytu BioScience and Corvus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Corvus Pharmaceuticals are associated (or correlated) with Aytu BioScience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aytu BioScience has no effect on the direction of Corvus Pharmaceuticals i.e., Corvus Pharmaceuticals and Aytu BioScience go up and down completely randomly.

Pair Corralation between Corvus Pharmaceuticals and Aytu BioScience

Given the investment horizon of 90 days Corvus Pharmaceuticals is expected to generate 0.92 times more return on investment than Aytu BioScience. However, Corvus Pharmaceuticals is 1.09 times less risky than Aytu BioScience. It trades about 0.05 of its potential returns per unit of risk. Aytu BioScience is currently generating about -0.16 per unit of risk. If you would invest  884.00  in Corvus Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of  25.00  from holding Corvus Pharmaceuticals or generate 2.83% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Corvus Pharmaceuticals  vs.  Aytu BioScience

 Performance 
       Timeline  
Corvus Pharmaceuticals 

Risk-Adjusted Performance

23 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Corvus Pharmaceuticals are ranked lower than 23 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Corvus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
Aytu BioScience 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aytu BioScience has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Corvus Pharmaceuticals and Aytu BioScience Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Corvus Pharmaceuticals and Aytu BioScience

The main advantage of trading using opposite Corvus Pharmaceuticals and Aytu BioScience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Corvus Pharmaceuticals position performs unexpectedly, Aytu BioScience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aytu BioScience will offset losses from the drop in Aytu BioScience's long position.
The idea behind Corvus Pharmaceuticals and Aytu BioScience pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments